Skip to content

BioLife Solutions BLFS Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-16.7%-18.3%
Returns
Return on invested capital-4.9%-4.2pp-5.4%-3.8pp-5%-5.2%-0.7%
Efficiency
Asset turnover0.3×+0.1×0.2×+0.1×0.2×0.2×0.2×
Liquidity
Current ratio7.3×+2.6×5.9×+1.4×4.7×+1.9×4.4×+1.6×4.7×+1.8×
Leverage
Debt-to-equity0.0×0.0×0.1×-0.1×0.1×0.0×0.1×0.0×
Per Share
Book value per share$7.56+3.7%$7.64+0.9%$7.26+3.0%$7.26+3.9%$7.29-0.7%
Valuation
Market capitalization$1.25B+23.8%$1.16B-3.3%$1.22B+5.8%$1.04B+5.0%$1.07B+27.5%
Price / sales12.5×-0.4×12.3×-3.8×13.5×12.3×13.7×
Price / book3.4×+0.5×3.1×-0.3×3.5×-0.1×-0.1×+0.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are BioLife Solutions's profit margins?
BioLife Solutions (BLFS) runs a 66.9% gross margin and a -16.7% operating margin, with a -68.7% net margin.
Where do BioLife Solutions's ratios come from?
Every ratio is computed from BioLife Solutions's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.